Guangping Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guangping Luo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Yanli Ji
Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China
2 shared publications Zhen Wang
Institute of Clinical Blood Transfusion, Guangzhou Blood Center Guangzhou People's Republic of China
2 shared publicationsAinong Sun
Department of Laboratory Medicine, Zhongshan Blood Center Zhongshan People's Republic of China
1 shared publicationB. Veldhuisen
Sanquin Research and Landsteiner Laboratory Academic Medical Centre University of Amsterdam Amsterdam The Netherlands
1 shared publication- C. Ellen van der Schoot
Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
1 shared publication H. Luo
Guangzhou Blood Center Institute of Clinical Blood Transfusion Guangzhou China
1 shared publication
Latest Publications
- 12 June 2021
- Published by Wiley in Transfusion
- Vol. 61 (8) , 2477-2486
Molecular genetic analysis of Mia‐positive hybrid glycophorins revealed two novel alleles of GP.Vw and multiple variant transcripts of GYPB existing in both the homozygous GP.Mur and wild‐type GPB individuals
Background: The hybrid glycophorins of MNS blood group system express a series of low incidence antigens including Mia, which are commonly found in Southeast Asian populations. In this study, the molecular basis of Mia‐positive hybrid glycophorins was firstly clarified in the Chinese Southern Han population. RNA transcripts of GYPB gene in the homozygous GP.Mur individuals were also analyzed.Study design and methods: DNAs were extracted from the whole blood samples of 111 Mia‐positive donors. Then, high‐resolution melting (HRM) analysis for GYP(B‐A‐B) was used to analyze the genotypes. Sequencing of GYPB pseudoexon 3 was conducted in the samples with variant melting curves. TA‐cloning and subsequent sequencing of GYPA exons 2–4 were performed in the Mia‐positive samples with normal GYPB/GYPB genotype by HRM. The transcript analysis of GYPB was conducted in homozygous GP.Mur and wild‐type glycophorin B (GPB) individuals using RNA extracted from the cultured erythroblast.Results: The heterozygous GYP*Mur/GYPB (n = 101), homozygous GYP*Mur/GYP*Mur (n = 7) including one novel GYP*Mur allele with an extra GYPA/GYPE specific nucleotide substitution (c.229+110A>T), heterozygous GYP*Bun/GYPB (n = 1) and GYP*Vw/GYPA (n = 2) with two novel GYP*Vw alleles were identified. RNA transcript analysis revealed multiple transcripts of GYPB existing in both homozygous GP.Mur and normal GPB individuals.Conclusion: The results showed the genetic diversity of hybrid glycophorins in the Chinese population. Besides, the successful analysis of GYPB transcripts indicates that the cultured erythroblast is a good source for RNA transcript analysis for the protein only expressed on the red blood cells.
- 12 June 2021
- Published by Wiley in Transfusion
- Vol. 61 (8) , 2477-2486
Molecular genetic analysis of Mia‐positive hybrid glycophorins revealed two novel alleles of GP.Vw and multiple variant transcripts of GYPB existing in both the homozygous GP.Mur and wild‐type GPB individuals
Background: The hybrid glycophorins of MNS blood group system express a series of low incidence antigens including Mia, which are commonly found in Southeast Asian populations. In this study, the molecular basis of Mia‐positive hybrid glycophorins was firstly clarified in the Chinese Southern Han population. RNA transcripts of GYPB gene in the homozygous GP.Mur individuals were also analyzed.Study design and methods: DNAs were extracted from the whole blood samples of 111 Mia‐positive donors. Then, high‐resolution melting (HRM) analysis for GYP(B‐A‐B) was used to analyze the genotypes. Sequencing of GYPB pseudoexon 3 was conducted in the samples with variant melting curves. TA‐cloning and subsequent sequencing of GYPA exons 2–4 were performed in the Mia‐positive samples with normal GYPB/GYPB genotype by HRM. The transcript analysis of GYPB was conducted in homozygous GP.Mur and wild‐type glycophorin B (GPB) individuals using RNA extracted from the cultured erythroblast.Results: The heterozygous GYP*Mur/GYPB (n = 101), homozygous GYP*Mur/GYP*Mur (n = 7) including one novel GYP*Mur allele with an extra GYPA/GYPE specific nucleotide substitution (c.229+110A>T), heterozygous GYP*Bun/GYPB (n = 1) and GYP*Vw/GYPA (n = 2) with two novel GYP*Vw alleles were identified. RNA transcript analysis revealed multiple transcripts of GYPB existing in both homozygous GP.Mur and normal GPB individuals.Conclusion: The results showed the genetic diversity of hybrid glycophorins in the Chinese population. Besides, the successful analysis of GYPB transcripts indicates that the cultured erythroblast is a good source for RNA transcript analysis for the protein only expressed on the red blood cells.
- 16 May 2021
- Published by Wiley in Transfusion Medicine
- Vol. 31 (4) , 271-276
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors
Objectives: To screen RhCE variants in the Chinese Southern Han donors for molecular genetic analysis.Background: More than hundreds of RhCE variant alleles have been described to resulting in weak and/or partial expression of RhCE antigens, generation of low‐prevalence antigens and/or absence of a high‐prevalence antigen of Rh system, which mainly reported in the people of African origin. In this study, the serological screening and molecular genetic analysis of RhCE variants were performed in the Chinese Southern Han donors.Methods: The blood samples of E(+) donors were preliminarily collected. Then, RhCE antigens of the E(+) samples were further typed by using two sets of monoclonal anti‐C, anti‐c, anti‐e and another anti‐E. When weak expression of RhCE antigens was found, direct sequencing for 10 exons ofRHCEgene,RHgenotyping analysis by using multiplex ligation–dependent probe amplification, flow cytometric analysis and even cDNA sequencing were performed.Results: A total of 4487 E(+) samples were collected and four samples with weak expression of antigens were detected.RHCE*Ce375GandRHCE*Ce667Tvariant alleles were identified in two samples with weak expression of e antigen, respectively. But no variant alleles were found in another two samples with weak expression of C antigen.Conclusion: The variantRHCE*Ce375Gvalidated by mRNA sequencing and the deducedRHCE*Ce667Talleles were firstly identified in the Chinese population. TheDCEhaplotype might account for the weak expression of C antigen in two donors.
- 16 May 2021
- Published by Wiley in Transfusion Medicine
- Vol. 31 (4) , 271-276
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors
Objectives: To screen RhCE variants in the Chinese Southern Han donors for molecular genetic analysis.Background: More than hundreds of RhCE variant alleles have been described to resulting in weak and/or partial expression of RhCE antigens, generation of low‐prevalence antigens and/or absence of a high‐prevalence antigen of Rh system, which mainly reported in the people of African origin. In this study, the serological screening and molecular genetic analysis of RhCE variants were performed in the Chinese Southern Han donors.Methods: The blood samples of E(+) donors were preliminarily collected. Then, RhCE antigens of the E(+) samples were further typed by using two sets of monoclonal anti‐C, anti‐c, anti‐e and another anti‐E. When weak expression of RhCE antigens was found, direct sequencing for 10 exons ofRHCEgene,RHgenotyping analysis by using multiplex ligation–dependent probe amplification, flow cytometric analysis and even cDNA sequencing were performed.Results: A total of 4487 E(+) samples were collected and four samples with weak expression of antigens were detected.RHCE*Ce375GandRHCE*Ce667Tvariant alleles were identified in two samples with weak expression of e antigen, respectively. But no variant alleles were found in another two samples with weak expression of C antigen.Conclusion: The variantRHCE*Ce375Gvalidated by mRNA sequencing and the deducedRHCE*Ce667Talleles were firstly identified in the Chinese population. TheDCEhaplotype might account for the weak expression of C antigen in two donors.
- 18 August 2017
- Published by Wiley in Vox Sanguinis
- Vol. 112 (7) , 660-670
RHD genotype and zygosity analysis in the Chinese Southern Han D+, D− and D variant donors using the multiplex ligation‐dependent probe amplification assay
Background and Objectives: Several comprehensive genotyping platforms for determining red blood cell (RBC) antigens have been established and validated for use in the Caucasian and Black populations, but not for the Chinese. The multiplex ligation‐dependent probe amplification (MLPA) assay was validated for RHD genotyping in the Chinese.Materials and Methods: The blood samples of 200 D+, 200 D− and 62 D variant Chinese donors were collected. RhD antigen was routinely typed by serological method. D variant phenotype was determined by an anti‐D panel (D‐Screen), when RBCs were available. The RHD genotype and its zygosity were analysed with the RH‐MLPA technique. When the MLPA was unable to identify a RHD variant, direct sequencing of all exons of the RHD gene was performed.Results: In 200 D+ donors, DD (168/200, 84%), D (12/200, 6%), DDD genotype (1/200) and D variant allele carriers (19/200, 9·5%) were found. In 200 D− donors, six reported RHD alleles, RHD*01EL.01, RHD*01N.03, RHD*01N.05, RHD*01N.16, RHD*DFR2 and RHD*weak partial 15 and one novel RHD*1154T allele were identified in 36·5% (73/200) of them. In 62 D variant donors, three novel RHD alleles, RHD*79_81delCTC, RHD*710T and RHD*689A, and twelve reported alleles, RHD*DVI.3, RHD*weak partial 15, RHD*DVI.4, RHD*01EL.01, RHD*01N.03, RHD*DLO, RHD*DV.5, RHD*D‐CE(2‐10), RHD*730C, RHD*weak D type 25, 33 and 72, were identified, either alone or in combination.Conclusion: The RH‐MLPA assay correctly identified the common RHD variant alleles in the Chinese population. However, DNA sequencing was required to identify certain alleles; probes to detect these alleles should be added into the assay.
- 18 August 2017
- Published by Wiley in Vox Sanguinis
- Vol. 112 (7) , 660-670
RHD genotype and zygosity analysis in the Chinese Southern Han D+, D− and D variant donors using the multiplex ligation‐dependent probe amplification assay
Background and Objectives: Several comprehensive genotyping platforms for determining red blood cell (RBC) antigens have been established and validated for use in the Caucasian and Black populations, but not for the Chinese. The multiplex ligation‐dependent probe amplification (MLPA) assay was validated for RHD genotyping in the Chinese.Materials and Methods: The blood samples of 200 D+, 200 D− and 62 D variant Chinese donors were collected. RhD antigen was routinely typed by serological method. D variant phenotype was determined by an anti‐D panel (D‐Screen), when RBCs were available. The RHD genotype and its zygosity were analysed with the RH‐MLPA technique. When the MLPA was unable to identify a RHD variant, direct sequencing of all exons of the RHD gene was performed.Results: In 200 D+ donors, DD (168/200, 84%), D (12/200, 6%), DDD genotype (1/200) and D variant allele carriers (19/200, 9·5%) were found. In 200 D− donors, six reported RHD alleles, RHD*01EL.01, RHD*01N.03, RHD*01N.05, RHD*01N.16, RHD*DFR2 and RHD*weak partial 15 and one novel RHD*1154T allele were identified in 36·5% (73/200) of them. In 62 D variant donors, three novel RHD alleles, RHD*79_81delCTC, RHD*710T and RHD*689A, and twelve reported alleles, RHD*DVI.3, RHD*weak partial 15, RHD*DVI.4, RHD*01EL.01, RHD*01N.03, RHD*DLO, RHD*DV.5, RHD*D‐CE(2‐10), RHD*730C, RHD*weak D type 25, 33 and 72, were identified, either alone or in combination.Conclusion: The RH‐MLPA assay correctly identified the common RHD variant alleles in the Chinese population. However, DNA sequencing was required to identify certain alleles; probes to detect these alleles should be added into the assay.